Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 205 Records) |
| Query Trace: Lung Neoplasms and Ros1[original query] |
|---|
| Liquid biopsy for the detection of resistance mutations to ROS1 and RET inhibitors in non-small lung cancers: A case series study. Respiratory investigation 2022 9 60 (6): 852-856. Seki Yoshitaka, Yoshida Tatsuya, Kohno Takashi, Masuda Ken, Okuma Yusuke, Goto Yasushi, Horinouchi Hidehito, Yamamoto Noboru, Kuwano Kazuyoshi, Ohe Yuichi |
| First-in-human phase I study of TQ-B3139 (CT-711) in advanced non-small cell lung cancer patients with ALK and ROS1 rearrangements. European journal of cancer (Oxford, England : 1990) 2022 Sep 173 238-249. Ma Yuxiang, Zhao Hongyun, Xue Jinhui, Liu Li, Yang Nong, Zhang Yang, Yang Haiyan, Hong Shaodong, Xiong Yi, Zhang Zhonghan, Zeng Liang, Pan Hui, Zhou Chunhua, Zhang Yongchang, Wang Xunqiang, Han Xi, Wan Xiaojing, Shao Yang, Liu Jingwen, Yang Yunpeng, Huang Yan, Zhao Yuanyuan, Fang Wenfeng, Li Su, Zhang |
| Analysis of actionable genetic alterations in lung carcinoma from the VA National Precision Oncology Program. Seminars in oncology 2022 Jul . Jalal Shadia I, Guo Aixia, Ahmed Sara, Kelley Michael |
| Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-small cell lung cancer: Subgroup analysis of a global phase 2 trial. Lung cancer (Amsterdam, Netherlands) 2022 Jul 169 67-76. Soo Ross A, Huat Tan Eng, Hayashi Hidetoshi, Seto Takashi, Lin Chia-Chi, Ou Sai-Hong Ignatius, Kim Dong-Wan, Liu Geoffrey, Abbattista Antonello, Martini Jean-François, Hooi Wong Chew, Toffalorio Francesca, Solomon Benjamin |
| A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib. BMC medical genomics 2022 Jun 15 (1): 141. Chen Yan, Jiang Bo, He Yuange, Zhang Chu, Zhou Wenjie, Fang Cheng, Gu Dejian, Zhang Minxia, Ji Mei, Shi Juntao, Yang X |
| Genetic determinants of lung cancer: Understanding the oncogenic potential of somatic missense mutations. Genomics 2022 6 114 (4): 110401. Dhakar Ramgopal, Dakal Tikam Chand, Sharma Am |
| The potential and limitation of targeted chromosomal breakpoint sequencing for the ROS1 fusion gene identification in lung cancer. American journal of cancer research 2022 6 12 (5): 2376-2386. Hung Ming-Szu, Lin Yu-Ching, Chen Fen-Fen, Jiang Yuan-Yuan, Fang Yu-Hung, Lu Ming-Shian, Lin Chin-Kuo, Yang Tsung-Ming, Lung Jrhau, Chen Chih-Cheng, Lee Kuan-Der, Tsai Ying-Hua |
| Clinicopathological Impact of the Spread through Air Space in Non-Small Cell Lung Cancer: A Meta-Analysis. Diagnostics (Basel, Switzerland) 2022 Apr 12 (5): . Pyo Jung-Soo, Kim Nae |
| An individual nomogram can reliably predict tumor spread through air spaces in non-small-cell lung cancer. BMC pulmonary medicine 2022 May 22 (1): 209. Wang Shuai, Shou Huankai, Wen Haoyu, Wang Xingxing, Wang Haixing, Lu Chunlai, Gu Jie, Xu Fengkai, Zhu Qiaoliang, Wang Lin, Ge |
| Genomic Alteration Spectrum of Non-Small Cell Lung Cancer Patients in East-China Characterized by Tumor Tissue DNA and Cell-Free DNA. OncoTargets and therapy 2022 5 15 571-584. Li Jie, Chen Siwen, Xue Hui, Wang Haoyi, Huang Tianwei, Xie Hongya, He Jiang, Ke Cai, Yu Zhaonan, Ni B |
| Genomic features of Chinese small cell lung cancer. BMC medical genomics 2022 May 15 (1): 117. Liu Jun, Zhao Zhuxiang, Wei Shuquan, Li Binkai, Zhao Ziw |
| The Clinically Actionable Molecular Profile of Early versus Late-Stage Non-Small Cell Lung Cancer, an Individual Age and Sex Propensity-Matched Pair Analysis. Current oncology (Toronto, Ont.) 2022 4 29 (4): 2630-2643. McGuire Anna L, McConechy Melissa K, Melosky Barb L, English John C, Choi James J, Peng Defen, Yee John, Furman Benjamin L S, Aguirre Hernandez Rosalia, Feijao Pedro, Mulder David, Hughesman Curtis, Yip Steph |
| ALK, ROS1 and EGFR status of lung cancers in the Aegean Region of Turkey. Indian journal of pathology & microbiology 2022 4 65 (2): 305-310. Diniz Gulden, Komurcuoglu Berna, Ozyilmaz Berk, Ozguzer Alp, Yucel Nur, Kirbiyik Ozg |
| Variation in targetable genomic alterations in non-small cell lung cancer by genetic ancestry, sex, smoking history, and histology. Genome medicine 2022 4 14 (1): 39. Adib Elio, Nassar Amin H, Abou Alaiwi Sarah, Groha Stefan, Akl Elie W, Sholl Lynette M, Michael Kesi S, Awad Mark M, J?nne Pasi A, Gusev Alexander, Kwiatkowski David |
| Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations. ESMO open 2022 Dec 7 (6): 100742. Wang H-Y, Wu S-G, Lin Y-T, Chen C-Y, Shih J |
| Actionable mutations in non-small cell lung cancer in patients at hospital de Especialidades Eugenio Espejo, Ecuador 2017-2020. Drug metabolism and personalized therapy 2022 12 . Fernández Freire Miguel Ángel, Gálvez Salazar Gabriela Isabel, Scudeler Mariana Meira, Rodrigues-Soares Fernanda, Jaramillo Koupermann Gabriela Fernanda, Moreno Ocampo Andrea Pao |
| Budget impact analysis of next-generation sequencing versus sequential single-gene testing in Japanese patients with advanced non-small-cell lung cancer. Respiratory investigation 2022 12 61 (1): 61-73. Matsuda Hiroyuki, Ogawa Toru, Sadatsuki Yasunari, Tsujino Toshiaki, Wada Shingo, Kim Seok-Won, Hatanaka Yuta |
| Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2022 12 . Ernst Sophie M, Mankor Joanne M, van Riet Job, von der Thüsen Jan H, Dubbink Hendrikus J, Aerts Joachim G J V, de Langen Adrianus J, Smit Egbert F, Dingemans Anne-Marie C, Monkhorst K |
| Concurrent classic driver oncogenes mutation with ROS1 rearrangement predicts superior clinical outcome in NSCLC patients. Genes & genomics 2022 11 45 (1): 93-102. Li Dandan, Jiang Hua, Jin Faguang, Pan Lei, Xie Yonghong, Zhang Liang, Li Chunm |
| The Role of Chemotherapy Plus Immune Checkpoint Inhibitors in Oncogenic-Driven NSCLC: A University of California Lung Cancer Consortium Retrospective Study. JTO clinical and research reports 2022 11 3 (12): 100427. Benjamin David J, Chen Shuai, Eldredge Joanna B, Schokrpur Shiruyeh, Li Debory, Quan Zhikuan, Chan Jason W, Cummings Amy L, Daly Megan E, Goldman Jonathan W, Gubens Matthew A, Harris Jeremy P, Onaitis Mark W, Zhu Viola W, Patel Sandip P, Kelly Kar |
| A large-scale prospective concordance study of plasma- and tissue-based next-generation targeted sequencing for advanced non-small cell lung cancer (LC-SCRUM-Liquid). Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Oct . Sugimoto Akira, Matsumoto Shingo, Udagawa Hibiki, Itotani Ryo, Usui Yuko, Umemura Shigeki, Nishino Kazumi, Nakachi Ichiro, Kuyama Shoichi, Daga Haruko, Hara Satoshi, Miyamoto Shingo, Kato Terufumi, Sakakibara-Konishi Jun, Tabata Eriko, Nakagawa Taku, Kawaguchi Tomoya, Sakai Tetsuya, Shibata Yuji, Izumi Hiroki, Nosaki Kaname, Zenke Yoshitaka, Yoh Kiyotaka, Goto Koic |
| SNP rs9387478 at ROS1-DCBLD1 Locus is Significantly Associated with Lung Cancer Risk and Poor Survival in Indian Population. Asian Pacific journal of cancer prevention : APJCP 2022 10 23 (10): 3553-3561. Chongtham Jonita, Pandey Namita, Sharma Lokesh Kumar, Mohan Anant, Srivastava Tapas |
| Genomic landscape of lung cancer in the young. Frontiers in oncology 2022 12 910117. Ruiz Rossana, Galvez-Nino Marco, Roque Katia, Montes Jaime, Nuñez Maria, Raez Luis, Sánchez-Gambetta Sergio, Jaúregui Sandra, Viale Sandra, Smith Edward S, Pinto Joseph A, Mas Lu |
| Analytical and clinical validation of a custom 15-gene next-generation sequencing panel for the evaluation of circulating tumor DNA mutations in patients with advanced non-small-cell lung cancer. PloS one 2022 17 (10): e0276161. Chow Yock Ping, Zainul Abidin Norziha, Kow Ken Siong, Tho Lye Mun, Wong Chieh L |
| The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature 2023 4 616 (7957): 525-533. Frankell Alexander M, Dietzen Michelle, Al Bakir Maise, Lim Emilia L, Karasaki Takahiro, Ward Sophia, Veeriah Selvaraju, Colliver Emma, Huebner Ariana, Bunkum Abigail, Hill Mark S, Grigoriadis Kristiana, Moore David A, Black James R M, Liu Wing Kin, Thol Kerstin, Pich Oriol, Watkins Thomas B K, Naceur-Lombardelli Cristina, Cook Daniel E, Salgado Roberto, Wilson Gareth A, Bailey Chris, Angelova Mihaela, Bentham Robert, Martínez-Ruiz Carlos, Abbosh Christopher, Nicholson Andrew G, Le Quesne John, Biswas Dhruva, Rosenthal Rachel, Puttick Clare, Hessey Sonya, Lee Claudia, Prymas Paulina, Toncheva Antonia, Smith Jon, Xing Wei, Nicod Jerome, Price Gillian, Kerr Keith M, Naidu Babu, Middleton Gary, Blyth Kevin G, Fennell Dean A, Forster Martin D, Lee Siow Ming, Falzon Mary, Hewish Madeleine, Shackcloth Michael J, Lim Eric, Benafif Sarah, Russell Peter, Boleti Ekaterini, Krebs Matthew G, Lester Jason F, Papadatos-Pastos Dionysis, Ahmad Tanya, Thakrar Ricky M, Lawrence David, Navani Neal, Janes Sam M, Dive Caroline, Blackhall Fiona H, Summers Yvonne, Cave Judith, Marafioti Teresa, Herrero Javier, Quezada Sergio A, Peggs Karl S, Schwarz Roland F, Van Loo Peter, Miedema Daniël M, Birkbak Nicolai J, Hiley Crispin T, Hackshaw Allan, Zaccaria Simone, , Jamal-Hanjani Mariam, McGranahan Nicholas, Swanton Charl |
| Efficacy of Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With ROS1-Rearranged Advanced Lung Adenocarcinoma: A Multicenter, Retrospective Cohort Study. JCO precision oncology 2023 3 7 e2200614. Huang Zhe, Yan Huan, Zeng Liang, Xu Qinqin, Guo Wenhuan, Lin Shaoding, Jiang Wenjuan, Wang Zhan, Deng Li, Qin Haoyue, Zhang Xing, Tong Fan, Zhang Ruiguang, Liu Zhaoyi, Zhang Lin, Dong Xiaorong, Yang Nong, Zhang Yongcha |
| Application of the Novel Grading System of Invasive Pulmonary Adenocarcinoma in a Real Diagnostic Scenario: A Brief Report of 9353 Cases. JTO clinical and research reports 2023 3 4 (3): 100465. She Yunlang, Zhong Yifan, Hou Likun, Zhao Shengnan, Zhang Liping, Xie Dong, Zhu Yuming, Wu Chunyan, Chen Cha |
| Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018. European journal of cancer (Oxford, England : 1990) 2023 2 183 38-48. Bylicki Olivier, Tomasini Pascale, Radj Gervais, Guisier Florian, Monnet Isabelle, Ricordel Charles, Bigay-Game Laurence, Geier Margaux, Chouaid Christos, Daniel Catherine, Swalduz Aurelie, Toffart Anne-Claire, Doubre Helene, Peloni Jean-Michel, Moreau Diane, Subtil Fabien, Grellard Jean-Michel, Castera Marie, Clarisse Benedicte, Martins-Lavinas Pedro-Henrique, Decroisette Chantal, Greillier Laurent, |
| Molecular characteristics and prognostic factors of leptomeningeal metastasis in non-small cell lung cancer. Clinical neurology and neurosurgery 2023 1 225 107572. Liu Xiaocui, Li Guangrui, Zhang Hongmei, Chang Qing, Fang Mei, Lu Chufan, Tian Panpan, Mei Fengj |
| Comparative study of the genomic landscape and tumor microenvironment among large cell carcinoma of the lung, large cell neuroendocrine of the lung, and small cell lung cancer. Medicine 2023 1 102 (4): e32781. Li Fanghua, Yang Yue, Xu Ying, Li Ke, Song Linhong, Xue Yang, Dong Dand |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 30, 2023
- Content source: